Polypharmacy: Difference between revisions

No edit summary
No edit summary
Line 76: Line 76:


<references />
<references />
[[Category:Older People/Geriatrics]]
[[Category:Pharmacology]]
[[Category:Pharmacology for Older People]]
[[Category:Global Health]]

Revision as of 15:06, 22 November 2020

Original Editor - Shwe Shwe U Marma Top Contributors - Shwe Shwe U Marma, Lucinda hampton and Kim Jackson

Introduction[edit | edit source]

Polypharmacy refers to the use of multiple medications in a patient, commonly an older adult.[1] While the most commonly used definition of polypharmacy is being on five or more medicines, definitions are variable.[2]

Catagories[edit | edit source]

There is no universally agreed definition of polypharmacy, however it can be described in 3 groups-

  1. Excessive polypharmacy (EPP): concurrent use of ten or more different drugs.
  2. Polypharmacy (PP): the use of five to nine drugs.
  3. No polypharmacy: taking four or less drugs (included those taking no medicines)[3]

Prevalence[edit | edit source]

  • Individuals greater than 65 years old are the biggest consumers of medications; however, evidence shows that greater than 50% of elderly patients are taking at least one medication that is not medically necessary. Nearly 40% of elderly adults take more than five prescription medications and almost 20% take more than 10.
  • Polypharmacy declines in patients older than 85 years of age secondary to poor drug tolerance with age and increasing deprescribing practices as medical providers fear serious adverse drug reactions that may be more common in the very elderly.[4]

Associated Factors[edit | edit source]

Individual/Patient Factors Physician Factors Systems-Level Factors
  • Increasing age
  • Female gender
  • White ethnicity/race
  • Lower socioeconomic status
  • Poor self-reported health
  • Multiple chronic conditions
  • Declining nutrition/ability to function
  • Decreased cognitive capacity
  • Self-medication
    • Use of over-the-counter medications
    • Borrowing from friends/family
  • Use of multiple pharmacies
  • Lack of education/competence
  • High patient workload
  • Prescribing habits
    • Adherence to multiple medical guidelines
    • Use of potentially inappropriate medications
  • Improper medication reconciliation
  • Poor physician-patient communication
  • Multiple prescribers
  • Different electronic medical record systems
  • Poor physician-physician communication
    • Lack of continuity between multiple medical providers
    • Ineffective transitions of care

[4]

Risks of Polypharmacy[edit | edit source]

  • Multiple medications together at the same time can result in storing or taking them in wrong way, which eventually may lead to prescribing errors by clinicians. For example, the same type of medication might be prescribed twice.
  • A medication may affect action of other medication which may result undesired effects.
  • A medication used to treat a disease might affect another disease negatively. For example, anti-inflammatory medications may increase blood pressure and worsen kidney function.[5]

Complications[edit | edit source]

This may result in various medication-related problems such as-

  • Adverse effects
  • Drug interactions
  • Inappropriate therapy, or nonadherence.[1]

Managing Polypharmacy[edit | edit source]

  • List of prescribed medication should be updated and accurate
  • Each clinician should review ongoing prescription
  • Physician should be informed of any supplements, herbal products or over-the-counter medication, a patient taking
  • Understanding the purpose of each medication
  • Being aware of side effects of each medications
  • Simplification of medication regimen
  • Discontinuation of any medication if needed
  • Taking medications as prescribed
  • Taking any prescribed medication should not be stopped suddenly[5]

Conclusion[edit | edit source]

Along with all other health practitioners, physiotherapists should be aware of the tools and methods to manage polypharmacy-related issues to optimize patient outcomes.[1]

References[edit | edit source]

  1. 1.0 1.1 1.2 Nguyen T, Wong E, Ciummo F. Polypharmacy in Older Adults: Practical Applications Alongside a Patient Case. The Journal for Nurse Practitioners. 2020 Mar 1;16(3):205-9.
  2. Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC geriatrics. 2017 Dec 1;17(1):230.
  3. O'Dwyer M, Peklar J, McCallion P, McCarron M, Henman MC. Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study. BMJ open. 2016 Apr 1;6(4).
  4. 4.0 4.1 Valenza PL, McGinley TC, Feldman J, Patel P, Cornejo K, Liang N, Anmolsingh R, McNaughton N. Dangers of polypharmacy. InVignettes in Patient Safety-Volume 1 2017 Sep 13. IntechOpen.
  5. 5.0 5.1 Onder G, Marengoni A. Polypharmacy. Jama. 2017 Nov 7;318(17):1728-.